{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Cancer", "Chinese medicinal plant", "Differentiation", "Drug screen", "ERK1/2 agonists", "Leukemia", "Melia azedarach"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31375085", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "08", "Day": "02"}], "Language": ["eng"], "ELocationID": ["764", "10.1186/s12885-019-5914-8"], "Journal": {"ISSN": "1471-2407", "JournalIssue": {"Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Aug", "Day": "02"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.", "Pagination": {"StartPage": "764", "MedlinePgn": "764"}, "Abstract": {"AbstractText": ["MAPK/ERK kinases transmit signals from many growth factors/kinase receptors during normal cell growth/differentiation, and their dysregulation is a hallmark of diverse types of cancers. A plethora of drugs were developed to block this kinase pathway for clinical application. With the exception of a recently identified agent, EQW, most of these inhibitors target upstream factors but not ERK1/2; no activator of ERK1/2 is currently available.", "A library of compounds isolated from medicinal plants of China was screened for anti-cancer activities. Three limonoid compounds, termed A1541-43, originally isolated from the plant Melia azedarach, exhibiting strong anti-leukemic activity. The anti-neoplastic activity and the biological target of these compounds were explored using various methods, including western blotting, flow cytometry, molecular docking and animal model for leukemia.", "Compounds A1541-43, exhibiting potent anti-leukemic activity, was shown to induce ERK1/2 phosphorylation. In contrast, the natural product Cedrelone, which shares structural similarities with A1541-43, functions as a potent inhibitor of ERK1/2. We provided evidence that A1541-43 and Cedrelone specifically target ERK1/2, but not the upstream MAPK/ERK pathway. Computational docking analysis predicts that compounds A1541-43 bind a region in ERK1/2 that is distinct from that to which Cedrelone and EQW bind. Interestingly, both A1541-43, which act as ERK1/2 agonists, and Cedrelone, which inhibit these kinases, exerted strong anti-proliferative activity against multiple leukemic cell lines, and induced robust apoptosis as well as erythroid and megakaryocytic differentiation in erythroleukemic cell lines. These compounds also suppressed tumor progression in a mouse model of erythroleukemia.", "This study identifies for the first time activators of ERK1/2 with therapeutic potential for the treatment of cancers driven by dysregulation of the MAPK/ERK pathway and possibly for other disorders."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Department of Immunology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, 550025, China."}], "LastName": "Wang", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Fan", "ForeName": "Yanhua", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Yuan", "ForeName": "Chun-Mao", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Song", "ForeName": "Jialei", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Yao", "ForeName": "Yao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, Ontario, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, 550025, China. liujlin63@yahoo.com."}], "LastName": "Liu", "ForeName": "Jielin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China. haoxj@mail.kib.ac.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China. haoxj@mail.kib.ac.cn."}], "LastName": "Hao", "ForeName": "Xiao Jiang", "Initials": "XJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Baiyun District, Guiyang, 550014, China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "GrantList": [{"GrantID": "6012-4001", "Agency": "the Science and Technology Department of Guizhou Province", "Country": ""}, {"GrantID": "WQ20135200171", "Agency": "the Thousand Talent Program of China", "Country": ""}, {"GrantID": "U1812403", "Agency": "Ministry of National Defense, People's Republic of China (CN)", "Country": ""}, {"GrantID": "81472609", "Agency": "the 100 Leading Talents of Guizhou Province", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Limonins"}, {"RegistryNumber": "0", "NameOfSubstance": "cedrelone"}, {"RegistryNumber": "EC 2.7.12.2", "NameOfSubstance": "Mitogen-Activated Protein Kinase Kinases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Differentiation"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "K562 Cells"}, {"QualifierName": ["drug therapy", "mortality", "pathology"], "DescriptorName": "Leukemia, Erythroblastic, Acute"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Limonins"}, {"QualifierName": ["drug effects"], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Melia azedarach"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinase Kinases"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Leaves"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Survival Rate"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330. doi: 10.3322/caac.21442.", "ArticleIdList": ["10.3322/caac.21442", "29313949"]}, {"Citation": "Xiao J, Zhang Q, Gao YQ, Tang JJ, Zhang AL, Gao JM. Secondary metabolites from the endophytic Botryosphaeria dothidea of Melia azedarach and their antifungal, antibacterial, antioxidant, and cytotoxic activities. J Agric Food Chem. 2014;62(16):3584\u20133590. doi: 10.1021/jf500054f.", "ArticleIdList": ["10.1021/jf500054f", "24689437"]}, {"Citation": "Zahoor M, Ahmed M, Naz S, Ayaz M. Cytotoxic, antibacterial and antioxidant activities of extracts of the bark of Melia azedarach (China berry) Nat Prod Res. 2015;29(12):1170\u20131172. doi: 10.1080/14786419.2014.982649.", "ArticleIdList": ["10.1080/14786419.2014.982649", "25426766"]}, {"Citation": "Della Bona A, Nedel F. Evaluation of Melia azedarach extracts against Streptococcus mutans. J Med Food. 2015;18(2):259\u2013263. doi: 10.1089/jmf.2013.0181.", "ArticleIdList": ["10.1089/jmf.2013.0181", "25069066"]}, {"Citation": "Akihisa T, Pan X, Nakamura Y, Kikuchi T, Takahashi N, Matsumoto M, et al. Limonoids from the fruits of Melia azedarach and their cytotoxic activities. Phytochemistry. 2013;89:59\u201370. doi: 10.1016/j.phytochem.2013.01.015.", "ArticleIdList": ["10.1016/j.phytochem.2013.01.015", "23465718"]}, {"Citation": "Cazal CM, Choosang K, Severino VG, Soares MS, Sarria AL, Fernandes JB, et al. Evaluation of effect of triterpenes and limonoids on cell growth, cell cycle and apoptosis in human tumor cell line. Anti Cancer Agents Med Chem. 2010;10(10):769\u2013776. doi: 10.2174/187152010794728620.", "ArticleIdList": ["10.2174/187152010794728620", "21269253"]}, {"Citation": "Fuzer AM, Filho JC, Becceneri AB, Dos Santos DA, da Silva MF, Vieira PC, et al. Effects of limonoid cedrelone on MDA-MB-231 breast tumor cells in vitro. Anti Cancer Agents Med Chem. 2013;13(10):1645\u20131653. doi: 10.2174/18715206113139990314.", "ArticleIdList": ["10.2174/18715206113139990314", "23869780"]}, {"Citation": "Khan MF, Rawat AK, Pawar B, Gautam S, Srivastava AK, Negi DS. Bioactivity-guided chemical analysis of Melia azedarach L. (Meliaceae), displaying antidiabetic activity. Fitoterapia. 2014;98:98\u2013103. doi: 10.1016/j.fitote.2014.07.014.", "ArticleIdList": ["10.1016/j.fitote.2014.07.014", "25062890"]}, {"Citation": "Pan X, Matsumoto M, Nakamura Y, Kikuchi T, Zhang J, Ukiya M, et al. Three new and other limonoids from the hexane extract of Melia azedarach fruits and their cytotoxic activities. Chem Biodivers. 2014;11(7):987\u20131000. doi: 10.1002/cbdv.201400052.", "ArticleIdList": ["10.1002/cbdv.201400052", "25044585"]}, {"Citation": "Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia. 2009;23(7):1311\u20131319. doi: 10.1038/leu.2009.20.", "ArticleIdList": ["10.1038/leu.2009.20", "19282832"]}, {"Citation": "Li YJ, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, et al. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2(1):e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8(10):16728\u201316743.", "ArticleIdList": ["PMC5369997", "28052010"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Yuan CM, Zhang Y, Tang GH, Li Y, He HP, Li SF, et al. Cytotoxic limonoids from Melia azedarach. Planta Med. 2013;79(2):163\u2013168.", "ArticleIdList": ["23250810"]}, {"Citation": "Gallardo-Vera Francisco, Tapia-Rodriguez Miguel, Diaz Daniel, Fortoul van der Goes Teresa, Monta\u00f1o Luis F., Rend\u00f3n-Huerta Erika P. Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways. Journal of Immunotoxicology. 2017;15(1):1\u201311. doi: 10.1080/1547691X.2017.1404662.", "ArticleIdList": ["10.1080/1547691X.2017.1404662", "29228829"]}, {"Citation": "Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999;286(5443):1358\u20131362. doi: 10.1126/science.286.5443.1358.", "ArticleIdList": ["10.1126/science.286.5443.1358", "10558990"]}, {"Citation": "Heightman TD, Berdini V, Braithwaite H, Buck IM, Cassidy M, Castro J, et al. Fragment-based discovery of a potent, orally bioavailable inhibitor that modulates the phosphorylation and catalytic activity of ERK1/2. J Med Chem. 2018;61(11):4978\u20134992. doi: 10.1021/acs.jmedchem.8b00421.", "ArticleIdList": ["10.1021/acs.jmedchem.8b00421", "29775310"]}, {"Citation": "Howard JC, Yousefi S, Cheong G, Bernstein A, Ben-David Y. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene. 1993;8(10):2721\u20132729.", "ArticleIdList": ["8378083"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5(6):908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Germann UA, Furey BF, Markland W, Hoover RR, Aronov AM, Roix JJ, et al. Targeting the MAPK signaling pathway in Cancer: promising preclinical activity with the novel selective ERK1/2 inhibitor BVD-523 (Ulixertinib) Mol Cancer Ther. 2017;16(11):2351\u20132363. doi: 10.1158/1535-7163.MCT-17-0456.", "ArticleIdList": ["10.1158/1535-7163.MCT-17-0456", "28939558"]}, {"Citation": "Corcoran RB, Settleman J, Engelman JA. Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancers. Oncotarget. 2011;2(4):336\u2013346. doi: 10.18632/oncotarget.262.", "ArticleIdList": ["10.18632/oncotarget.262", "PMC3248170", "21505228"]}, {"Citation": "Little AS, Smith PD, Cook SJ. Mechanisms of acquired resistance to ERK1/2 pathway inhibitors. Oncogene. 2013;32(10):1207\u20131215. doi: 10.1038/onc.2012.160.", "ArticleIdList": ["10.1038/onc.2012.160", "22562245"]}, {"Citation": "Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle. 2009;8(8):1168\u20131175. doi: 10.4161/cc.8.8.8147.", "ArticleIdList": ["10.4161/cc.8.8.8147", "PMC2728430", "19282669"]}, {"Citation": "Crispino JD, Weiss MJ. Erythro-megakaryocytic transcription factors associated with hereditary anemia. Blood. 2014;123(20):3080\u20133088. doi: 10.1182/blood-2014-01-453167.", "ArticleIdList": ["10.1182/blood-2014-01-453167", "PMC4023417", "24652993"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "10"}, {"Year": "2019", "Month": "7", "Day": "9"}, {"Year": "2019", "Month": "8", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["31375085", "PMC6679490", "10.1186/s12885-019-5914-8", "10.1186/s12885-019-5914-8"]}}]}